We are currently developing a new site to host the Patent Manual of Practice and Procedure. The BETA version of this site is now available for you to review. The information and content displayed in the BETA site is only available for testing purposes. Do not use or reference the information in the BETA site when making any decisions or actions regarding IP rights. Useful (Utility)

Date Published

Note: The information in this part only applies to:

  • standard patent applications with an examination request filed before 15 April 2013.  
  • innovation patents with an examination request filed before 15 April 2013.
  • innovation patents where the Commissioner decided before 15 April 2013 to examine the patent.

For all other standard patent applications/innovation patents, see Useful (Utility).

During examination of a standard patent application or an innovation patent, examiners are not required to consider whether a claimed invention satisfies the requirement that it be useful (sec 18(1)(c) and sec 18(1A)(c) respectively).

However, examiners are required to consider the use to which an invention is to be put. Since an application must be in respect of a manner of manufacture, it is essential that the specification indicates an area of usefulness for the invention claimed, where such use is not self evident. Where no use is described (either implicitly or explicitly), the claims may be directed to a mere scientific curiosity, discovery or idea. In these situations, examiners should object that the claims are not directed to a manner of manufacture, as well as that the specification does not fully describe the invention.

The use of many inventions is self-evident, or may be implied in the specification (e.g. a motor vehicle), and in such circumstances no formal statement of use is required. Where there is a statement of use, but the statement is so broad that it merely indicates that an invention has been made without disclosing what that invention is, an objection or objections should be taken as outlined above.  For example, a class of chemical compounds may be stated to be "pharmaceutically active". This is insufficient to indicate the nature of the invention; if the compounds are active as analgesics or hypnotics, this should be specified.

Similarly, if a claim defines a DNA sequence, it is insufficient to describe the sequence as being broadly useful as a "probe". The specification must disclose a specific gene which can be probed by the DNA sequence or a specific use.

Back to top